Olumiant 4 mg (Baricitinib)
| Active Ingredient | Baricitinib |
|---|---|
| Indication: | Rheumatoid arthritis |
| Manufacturer: | Eli Lilly and Company India |
| Packaging | 7 tablets in 1 strip |
| Strength | 4mg |
| Delivery Time | 6 To 15 days |
Olumiant 4 mg contains baricitinib, an oral Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis in adults. It helps reduce joint pain, swelling, and stiffness by blocking inflammatory pathways responsible for autoimmune activity. Olumiant is also approved for treating alopecia areata and, in some cases, COVID-19 complications under medical supervision.
This once-daily tablet is prescribed when patients do not respond adequately to conventional disease-modifying antirheumatic drugs (DMARDs). Baricitinib targets specific enzymes in the immune system to reduce inflammation and slow disease progression.
Possible side effects include upper respiratory infections, nausea, blood clots, and changes in lab values. Regular blood tests are recommended during treatment. Olumiant 4 mg can help improve mobility, reduce flare-ups, and enhance quality of life in chronic inflammatory conditions.








There are no reviews yet.